header
February 4, 2019

In This Issue
IN THE SPOTLIGHT
State House Report: MMA Testifies on Gun Violence and Patient Protection Bills
MMA Wants Your Feedback: Physician Wellness Survey
E-cigarettes Better Than Other Nicotine Replacement Therapies
Azar Proposes Shifting Drug Rebates From PBMs to Consumers
AMA State Advocacy Summit: 8 Physician Advocacy Wins that Set the Stage for 2019
Researchers Say Outpatient Use of Benzodiazepines Increasing
129th MAINE LEGISLATURE
MMA Legislative Call Tuesday, February 5th
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Enrollment Underway for Maine’s Physician Executive Leadership Institute - The Advanced Course - Deadline Extended to February 8, 2019
Webinar Presented by Baystate Financial - Sources of Retirement Income - Tuesday, February 12th
Identifying Substance Use Early Saves Lives! - SBIRT with Motivational Interviewing Training - 1-day Sessions Offered on March 2 and April 6
NAMI Maine’s Beyond the Basics in Suicide Prevention Conference - Friday, April 12, 2019
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Psychiatric Mental Health NP - Leeds
Urgent Care Physician - South Portland, ME
PCHC in need of Pediatrician at Multiple Locations!
Outpatient Internal Medicine Physician – Bangor, Maine
Full-time Board Certified/Board Eligible MD/DO
Outpatient Family Medicine - Brunswick, Maine
Psychiatric Nurse Practitioner - Nasson Health Care
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health

 
Search Back Issues





 




Follow Us:
Azar Proposes Shifting Drug Rebates From PBMs to Consumers

[from AMA Morning Rounds]

The Washington Post (1/31, Rowland) reports that on Thursday, the Trump administration “proposed bringing transparency to one of the most secretive aspects of drug pricing by ending the widespread practice of rebates to middlemen – an effort to reduce what consumers pay for prescription medicine.” Under the proposal announced by HHS Secretary Alex Azar, “drug manufacturers would be allowed to offer discounted prices directly to consumers but would no longer be able to give rebates to the middlemen, known as pharmacy benefit managers.” The article says if the rules take effect in 2020, they “would apply directly to older Americans who buy medicine under Medicare drug plans and low-income people with Medicaid managed-care plans.”

Bloomberg News (1/31, Edney, Langreth) reports that the proposal could end “a complex system of drug rebates that influence tens of billions of dollars in U.S. pharmaceutical spending, a move that could upend the relationship between drugmakers and pharmacy benefits middlemen.”

 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©